AstraZeneca slides after report of Bristol Myers merger talks leaves analysts 'perplexed'

AstraZeneca and Bristol Myers Squibb have discussed a potential merger over several months, according to CNBC. News of the talks sent AstraZeneca shares down. Analysts are reportedly perplexed by the move.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton